Followers | 16 |
Posts | 1295 |
Boards Moderated | 0 |
Alias Born | 11/15/2007 |
Tuesday, March 14, 2017 10:40:51 PM
German Reimbursement Authority Renews Medovex Corporations Reimbursement Payment Coding for the DenerveX(TM) System
ATLANTA, GA -- (Marketwired) -- 03/13/17 -- Medovex Corp. (NASDAQ: MDVX), a developer of medical technology products, today announced that the reimbursement authority in Germany has renewed reimbursement payment coding for the DenerveX™ System technology for the treatment of the Facet Joint Syndrome for 2017.
The renewed reimbursement coding, effective immediately, was released in the Diagnosis- Related Group (DRG) system in 2017 in Germany. This new coding allows for hospitals and outpatient centers to receive reimbursement for the use of the DenerveX System for the treatment of the Facet Joint Syndrome in the spine.
According to Manfred Sablowski, Senior Vice President Global Sales & Marketing of Medovex, "The renewal of the reimbursement code for 2017 in Germany will be a significant driver for our European launch preparation for the DenerveX System. Germany is often recognized as a leader in early clinical adoption of new and cost effective technologies, being on the forefront of establishing reimbursement guidelines, and with other countries often following its lead. Reimbursement is perhaps the most foundational element supporting adoption for a medical technology. It's for this reason, amongst others, that we are very pleased to again have successfully secured the codes issuance."
Sablowski continued, "We are encouraged that Germany provides reimbursement for our DenerveX System." Germany is ranked as one of the top healthcare systems globally based upon measurements of the overall level and distribution of health, responsiveness, and financial contribution to healthcare services."
The Company's patented DenerveX System, is not yet commercially available, is designed to provide longer lasting relief of pain associated with the facet joint. Lower back pain is the second most common cause of disability in the U.S. for adults. Studies indicate that 10% of the U.S. adult population suffers from lower back pain and that 31% of lower back pain is attributed to facet joint pain.
The DenerveX System consists of the DenerveX device, a single use device, and the DenerveX Pro-40 Power Generator. The DenerveX system is designed to provide a minimally invasive treatment option which combines two actions into one device.
Recent IVRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 02:26:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 04:52:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 09:22:02 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM